Global Assistive Reproductive Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Assistive Reproductive Market Insights, Forecast to 2034
Assisted reproductive technology (ART) are the medical procedures used for infertility treatment, in which eggs are surgically removed from the ovaries and are combined with the sperms in a laboratory.
Market Analysis and InsightsGlobal Assistive Reproductive Market
Global Assistive Reproductive market is expected to reach to US$ 29120 million in 2023, with a positive growth of %, compared with US$ 28150 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Assistive Reproductive industry is evaluated to reach US$ 38130 million in 2033. The CAGR will be 4.6% during 2023 to 2033.
The Assisted Reproductive Technology (ART) market is primarily driven by the increasing demand for fertility treatments and solutions to overcome infertility challenges. ART encompasses a range of medical procedures and technologies that aid individuals and couples in achieving pregnancy. The growing prevalence of infertility due to various factors such as age, lifestyle, and medical conditions, coupled with advancements in reproductive medicine and technology, contributes to market growth. Moreover, the demonstrated success of ART methods such as in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) in helping couples conceive further propels adoption. However, challenges include addressing ethical considerations, optimizing treatment protocols, and managing the emotional and psychological aspects of fertility treatments. Navigating legal regulations, ensuring affordability and accessibility, and providing comprehensive patient support are ongoing concerns. The market's success relies on continuous research in reproductive health, collaborations between fertility clinics and medical manufacturers, and comprehensive patient education on the benefits and potential challenges of using ART while addressing the evolving challenges associated with infertility treatment and family planning.
Report Covers
This report presents an overview of global Assistive Reproductive market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Assistive Reproductive market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Cooper Surgical
Hamilton Thorne
FUJIFILM Irvine Scientific
Nidacon International
Vitrolife AB
Merck
INVO Bioscience
IVFtech
Gonagen Medikal
Cook Medical
CellCura
Segment by Type
In-vitro fertilization (IVF)
Artificial Insemination-Intrauterine Insemination (AI-IUI)
Frozen Embryo Replacement (FER)
Other
Fertility Clinics
IVF Center
Hospital
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Assistive Reproductive introduction, etc. Assistive Reproductive Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Assistive Reproductive
Chapter 13Methodology and Data Sources adopted by MRAResearch
Market Analysis and InsightsGlobal Assistive Reproductive Market
Global Assistive Reproductive market is expected to reach to US$ 29120 million in 2023, with a positive growth of %, compared with US$ 28150 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Assistive Reproductive industry is evaluated to reach US$ 38130 million in 2033. The CAGR will be 4.6% during 2023 to 2033.
The Assisted Reproductive Technology (ART) market is primarily driven by the increasing demand for fertility treatments and solutions to overcome infertility challenges. ART encompasses a range of medical procedures and technologies that aid individuals and couples in achieving pregnancy. The growing prevalence of infertility due to various factors such as age, lifestyle, and medical conditions, coupled with advancements in reproductive medicine and technology, contributes to market growth. Moreover, the demonstrated success of ART methods such as in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) in helping couples conceive further propels adoption. However, challenges include addressing ethical considerations, optimizing treatment protocols, and managing the emotional and psychological aspects of fertility treatments. Navigating legal regulations, ensuring affordability and accessibility, and providing comprehensive patient support are ongoing concerns. The market's success relies on continuous research in reproductive health, collaborations between fertility clinics and medical manufacturers, and comprehensive patient education on the benefits and potential challenges of using ART while addressing the evolving challenges associated with infertility treatment and family planning.
Report Covers
This report presents an overview of global Assistive Reproductive market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Assistive Reproductive market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Cooper Surgical
Hamilton Thorne
FUJIFILM Irvine Scientific
Nidacon International
Vitrolife AB
Merck
INVO Bioscience
IVFtech
Gonagen Medikal
Cook Medical
CellCura
Segment by Type
In-vitro fertilization (IVF)
Artificial Insemination-Intrauterine Insemination (AI-IUI)
Frozen Embryo Replacement (FER)
Other
Segment by Application
Fertility Clinics
IVF Center
Hospital
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Assistive Reproductive introduction, etc. Assistive Reproductive Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Assistive Reproductive
Chapter 13Methodology and Data Sources adopted by MRAResearch